Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**High molecular weight hyaluronic acid + low molecular weight hyaluronic acid** is a combination formulation of hyaluronic acid polymers differentiated by size. This product leverages the distinct properties of each molecular weight for synergistic benefit. High molecular weight hyaluronic acid (HMW-HA) typically forms a surface film, providing immediate hydration, plumping effects, and a moisture barrier, but exhibits limited skin penetration. Low molecular weight hyaluronic acid (LMW-HA) penetrates deeper into the skin layers, promoting longer-lasting hydration and potentially stimulating healing processes. Used topically in skin care, this multiscale formulation aims to deliver both instant surface hydration and lasting moisturization throughout epi- and dermal layers. In medical contexts, hyaluronic acid of varying molecular weights is used for intra-articular injection in osteoarthritis and wound healing, with HMW-HA showing evidence for pain relief and improved function. The mechanism of action is primarily through water retention, tissue hydration, barrier reinforcement, and modulation of cell behavior in skin and joints.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on high molecular weight hyaluronic acid + low molecular weight hyaluronic acid.